Dr Sam Jayanth Samuel, MD | |
2223 W State St, Olean, NY 14760-1938 | |
(716) 372-5601 | |
Not Available |
Full Name | Dr Sam Jayanth Samuel |
---|---|
Gender | Male |
Speciality | Internal Medicine - Gastroenterology |
Location | 2223 W State St, Olean, New York |
Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
Identifier | Type | State | Issuer |
---|---|---|---|
1184886004 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
207R00000X | Internal Medicine | 233868 (New York) | Secondary |
207RG0100X | Internal Medicine - Gastroenterology | 233868 (New York) | Primary |
Entity Name | Olean General Hospital |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1649296781 PECOS PAC ID: 9133111784 Enrollment ID: O20040401001531 |
News Archive
An international consortium of scientists, including a team from The University of Queensland's Institute for Molecular Bioscience (IMB), is a step closer to the next generation of treatments to combat disease, after publishing a comprehensive analysis of the human and mouse transcriptomes.
The Senate Health, Education, Labor and Pensions Committee began amending their version of sweeping health overhaul legislation Thursday, days after a Congressional Budget Office report found the bill would cost $1 trillion over ten years, leaving 37 million people uninsured and Senate Republicans skeptical, the Associated Press reports.
Poor mental health, self-harm and suicide attempts are common among children and adolescents who have been trafficked for forced labour or sexual exploitation, according to a new study published in JAMA Pediatrics.
Keryx Biopharmaceuticals, Inc., a biopharmaceutical company focused on the acquisition, development and commercialization of medically important pharmaceutical products for the treatment of cancer and renal disease, today announced its results for the first quarter ended March 31, 2011.
› Verified 8 days ago
Entity Name | Mercy Hospital Of Buffalo |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1164464921 PECOS PAC ID: 8729991666 Enrollment ID: O20040702001253 |
News Archive
An international consortium of scientists, including a team from The University of Queensland's Institute for Molecular Bioscience (IMB), is a step closer to the next generation of treatments to combat disease, after publishing a comprehensive analysis of the human and mouse transcriptomes.
The Senate Health, Education, Labor and Pensions Committee began amending their version of sweeping health overhaul legislation Thursday, days after a Congressional Budget Office report found the bill would cost $1 trillion over ten years, leaving 37 million people uninsured and Senate Republicans skeptical, the Associated Press reports.
Poor mental health, self-harm and suicide attempts are common among children and adolescents who have been trafficked for forced labour or sexual exploitation, according to a new study published in JAMA Pediatrics.
Keryx Biopharmaceuticals, Inc., a biopharmaceutical company focused on the acquisition, development and commercialization of medically important pharmaceutical products for the treatment of cancer and renal disease, today announced its results for the first quarter ended March 31, 2011.
› Verified 8 days ago
Entity Name | Health System Physician Pc |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1649600081 PECOS PAC ID: 7113150285 Enrollment ID: O20140428000044 |
News Archive
An international consortium of scientists, including a team from The University of Queensland's Institute for Molecular Bioscience (IMB), is a step closer to the next generation of treatments to combat disease, after publishing a comprehensive analysis of the human and mouse transcriptomes.
The Senate Health, Education, Labor and Pensions Committee began amending their version of sweeping health overhaul legislation Thursday, days after a Congressional Budget Office report found the bill would cost $1 trillion over ten years, leaving 37 million people uninsured and Senate Republicans skeptical, the Associated Press reports.
Poor mental health, self-harm and suicide attempts are common among children and adolescents who have been trafficked for forced labour or sexual exploitation, according to a new study published in JAMA Pediatrics.
Keryx Biopharmaceuticals, Inc., a biopharmaceutical company focused on the acquisition, development and commercialization of medically important pharmaceutical products for the treatment of cancer and renal disease, today announced its results for the first quarter ended March 31, 2011.
› Verified 8 days ago
Mailing Address | Practice Location Address |
---|---|
Dr Sam Jayanth Samuel, MD 8520 Stahley Rd, East Amherst, NY 14051-1540 Ph: (716) 636-5651 | Dr Sam Jayanth Samuel, MD 2223 W State St, Olean, NY 14760-1938 Ph: (716) 372-5601 |
News Archive
An international consortium of scientists, including a team from The University of Queensland's Institute for Molecular Bioscience (IMB), is a step closer to the next generation of treatments to combat disease, after publishing a comprehensive analysis of the human and mouse transcriptomes.
The Senate Health, Education, Labor and Pensions Committee began amending their version of sweeping health overhaul legislation Thursday, days after a Congressional Budget Office report found the bill would cost $1 trillion over ten years, leaving 37 million people uninsured and Senate Republicans skeptical, the Associated Press reports.
Poor mental health, self-harm and suicide attempts are common among children and adolescents who have been trafficked for forced labour or sexual exploitation, according to a new study published in JAMA Pediatrics.
Keryx Biopharmaceuticals, Inc., a biopharmaceutical company focused on the acquisition, development and commercialization of medically important pharmaceutical products for the treatment of cancer and renal disease, today announced its results for the first quarter ended March 31, 2011.
› Verified 8 days ago
Dr. Neha Bansal, M.D. Gastroenterology Medicare: Accepting Medicare Assignments Practice Location: 535 Main St, Olean, NY 14760 Phone: 716-372-0141 Fax: 716-372-6421 | |
Arkady Peterman, M.D, Gastroenterology Medicare: Not Enrolled in Medicare Practice Location: 535 Main St, Olean, NY 14760 Phone: 716-372-0141 Fax: 716-376-2451 | |
Dr. Zafar K Mirza, MD Gastroenterology Medicare: Accepting Medicare Assignments Practice Location: 2223 W State St, Suite 115, Olean, NY 14760 Phone: 716-372-5601 Fax: 716-372-5616 | |
Dr. Munir Ahmed Salimi, MD Gastroenterology Medicare: Accepting Medicare Assignments Practice Location: 2223 W State St, Suite 114, Olean, NY 14760 Phone: 716-372-8660 Fax: 716-372-8684 | |
Dr. Zia M Sheikh, M.D. Gastroenterology Medicare: Accepting Medicare Assignments Practice Location: 2211 W State St, Suite 121, Olean, NY 14760 Phone: 716-372-2355 Fax: 716-372-8682 | |
Dr. Prerna Sood, M.D. Gastroenterology Medicare: Accepting Medicare Assignments Practice Location: 535 Main St, Olean, NY 14760 Phone: 716-372-0141 Fax: 716-372-6421 |